Cardiovascular Outcomes Group, Leon H. Charney Division of Cardiology, New York University School of Medicine, 550 First Avenue, SKI 9R/109, New York, NY, USA.
Pharmerit International, LP, 4350 East West Hwy, Suite #1110, Bethesda, MD, USA.
Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):258-266. doi: 10.1093/ehjqcco/qcy023.
The association between depression care adequacy and the risk of subsequent adverse cardiovascular disease (CVD) outcomes among patients with a previous diagnosis of myocardial infarction (MI) or stroke is not well defined.
This retrospective cohort study used commercial claims data (2010-2015) and included adults with newly diagnosed and treated major depressive disorder (MDD) following an initial MI or stroke diagnosis. Depression care adequacy was assessed during the 3-month period following the MDD diagnosis index date using two measures: antidepressant dosage adequacy and duration adequacy. Cox models adjusted for the propensity of receiving adequate depression care were used to compare the risk of a composite CVD outcome (MI, stroke, congestive heart failure, and angina) as well as each individual CVD event between patients receiving adequate vs. inadequate depression care. A total of 1568 patients were included in the final cohort. Of these, 937 (59.8%) were categorized as receiving inadequate depression care based on at least one of the two treatment adequacy criteria. Propensity score adjusted Cox models showed that depression care inadequacy was associated with a significantly higher risk of the composite CVD endpoint [hazard ratio (HR) 1.20, 95% confidence interval (CI) 1.04-1.39], stroke (HR 1.20, 95% CI 1.02-1.42), and angina (HR 1.95, 95% CI 1.21-3.16) with no significant interaction based on cohort included (MI vs. stroke) or the definition of inadequate depression (dose vs. duration inadequacy) (Pinteraction > 0.05).
Inadequate MDD care was associated with a higher risk of adverse CVD events. These findings reveal a significant unmet clinical need in patients with post-MI or post-stroke MDD that may impact CVD outcomes.
在先前被诊断患有心肌梗死(MI)或中风的患者中,抑郁治疗的充分性与随后发生不良心血管疾病(CVD)结局的风险之间的关系尚不清楚。
本回顾性队列研究使用商业索赔数据(2010-2015 年),纳入了在首次 MI 或中风诊断后新诊断和治疗的重度抑郁症(MDD)的成年人。使用两种措施评估 MDD 诊断索引日期后 3 个月内的抑郁治疗充分性:抗抑郁药剂量充分性和持续时间充分性。使用调整充分接受抑郁治疗可能性的 Cox 模型比较接受充分和不充分抑郁治疗的患者之间的复合 CVD 结局(MI、中风、充血性心力衰竭和心绞痛)以及每种 CVD 事件的风险。最终队列共纳入 1568 名患者。其中,根据至少一项治疗充分性标准,有 937 名(59.8%)患者被归类为接受不充分的抑郁治疗。倾向评分调整 Cox 模型显示,抑郁治疗不充分与复合 CVD 终点(危险比 [HR] 1.20,95%置信区间 [CI] 1.04-1.39)、中风(HR 1.20,95% CI 1.02-1.42)和心绞痛(HR 1.95,95% CI 1.21-3.16)的风险显著增加,且基于纳入的队列(MI 与中风)或不充分抑郁的定义(剂量与持续时间不充分)无显著交互作用(P 交互作用>0.05)。
不充分的 MDD 治疗与不良 CVD 事件的风险增加相关。这些发现揭示了 MI 后或中风后 MDD 患者存在显著的未满足的临床需求,可能会影响 CVD 结局。